Antibiotic Prophylaxis is used in this trial to prevent infections caused by Group G/C Streptococcus bacteria during labor and after childbirth. The antibiotics are given to the mother during labor to reduce the risk of infection for both the mother and the newborn. This approach aims to protect against potential complications that can arise from these bacterial infections.

Group G Streptococcus Infection – This infection is caused by Group G Streptococcus bacteria, which can be part of the normal flora in the human body but may lead to infections under certain conditions. In pregnant women, these bacteria can be found in the vaginal-rectal area and may pose a risk during childbirth. The infection can progress to cause postpartum complications in the mother, such as fever and inflammation, requiring medical attention. It can also affect the newborn, potentially leading to serious health issues if not managed properly. The bacteria can spread through direct contact during delivery, making it important to monitor and manage the condition to prevent transmission.

Group C Streptococcus Infection – This infection is caused by Group C Streptococcus bacteria, which are similar to Group G in that they can be part of the normal flora but may cause disease under certain circumstances. In pregnant women, these bacteria can be present in the vaginal-rectal area and may lead to complications during and after childbirth. The infection can result in postpartum issues for the mother, such as fever and inflammation, which may require antibiotic treatment. It can also pose a risk to the newborn, potentially leading to infections if not properly addressed. The bacteria can be transmitted during delivery, necessitating careful monitoring and management to prevent complications.